Reply  by Marenzi, Giancarlo et al.
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455balance. In the control group, during the 25  2-h treatment
period, the cumulative saline hydration was 1,742  290 ml.
mportantly, however, urine output during hydration in the control
roup was 3,117  876 ml. Thus, the control group had a net
egative fluid balance. The reason for this finding is not entirely
lear. It is possible that continuing the diuretics that both groups
f patients were on as outpatients caused this finding. Forty-eight
f 83 (58%) of patients in the control group were on diuretics, and
here was no protocol to stop these medications before the
ntervention. Thus, the differences in the fluid administered and
he fluid balance achieved likely influenced the results of the study
n the 2 groups.
Majumdar et al. (2) in their meta-analysis comparing furosemide-
ased intervention with saline hydration for the prevention of CIN
oncluded furosemide-based interventions to be detrimental to
aline hydration for the prevention of CIN. However, the studies
hat were analyzed did not have as rigorous a method of hydration
n the intervention arms as did the study by Marenzi et al. (1).
In light of prior randomized controlled trials, to demonstrate
enefit of furosemide-based intervention with hydration over
aline hydration alone for the prevention of CIN, it is critical to
eep both study arms equally hydrated. Failure to do so may
nfluence the results of the study. Thus, studies maintaining equal
ydration in both groups are needed to demonstrate a difference in
utcome due to the intervention.
Deep Sharma, MD
Department of Nephrology
lbert Einstein College of Medicine/
ontefiore Medical Center
llmann Building Room 615
300 Morris Park Avenue
ronx, New York 10461
-mail: dsharma@montefiore.org
doi:10.1016/j.jcin.2012.02.007
REFERENCES
1. Marenzi G, Ferrari C, Marana I, et al. Prevention of contrast nephrop-
athy by furosemide with matched hydration: the MYTHOS (Induced
Diuresis With Matched Hydration Compared to Standard Hydration
for Contrast Induced Nephropathy Prevention) trial. J Am Coll Cardiol
Intv 2012;5:90–7.
2. Majumdar SR, Kjellstrand CM, Tymchak WJ, Hervas-Malo M, Taylor
DA, Teo KK. Forced euvolemic diuresis with mannitol and furosemide
for prevention of contrast-induced nephropathy in patients with CKD
undergoing coronary angiography: a randomized controlled trial. Am J
Kidney Dis 2009;54:602–9.
Reply
We appreciate the thoughtful comments of Drs. Chauhan and
Sharma on our study. We agree with them with regard to the
critical importance of generous hydration and positive fluid balance
for contrast-induced nephropathy prevention. Current guidelines
recommend administration of isotonic electrolyte solutions at an
infusion rate of 1.0 ml/kg/h or less (0.5 ml/kg/h) in case of leftventricular ejection fraction35% or New York Heart Association
functional class 2 (1). We believe that this hydration rate
represents a “safe” regimen conceived for avoiding fluid overload
and pulmonary edema rather than an “effective” patient hydration.
Indeed, a 70-ml/h hydration rate for 24 h in a 70 kg fasting patient
is the minimal fluid volume needed to avoid dehydration. By
contrast, vigorous hydration before coronary procedures is difficult
logistically and poorly tolerated, in particular in the presence of
impaired cardiac and renal function. Thus, despite general agree-
ment on hydration benefit and strong recommendation of all
guidelines, most patients are not sufficiently hydrated in routine
clinical practice.
In our study (2), saline infusion and urine output were rigor-
ously measured. However, from these data it is not possible to
extrapolate the net fluid balance, because all patients were encour-
aged to freely drink water after coronary angiography. Thus, it is
likely that the control group too had a modestly positive or, at
worst, a slightly negative fluid balance.
Although further studies are needed to elucidate the mecha-
nisms of the innovative preventive treatment described in our
report, it is unlikely that its beneficial effects might be explained by
the initial 250-ml saline bolus only. We believe that simultaneous
high urine-flow rate resulting from furosemide administration
together with dehydration prevention obtained by exactly match-
ing saline infusion might have played an important role in the
results observed in the treated patients. Indeed, preclinical studies
demonstrated that prolonged contact time of contrast with the
tubular epithelial cells is associated with a greater tubular damage,
as indicated by biomarkers (3), and that high urine-flow rates flush
the renal tubules and lower contrast concentration in tubular fluid.
This accelerates contrast excretion, thus reducing the exposure
time of tubular cells. Therefore, the high urine-flow rate achievable
with this innovative treatment might lower contrast concentration
and viscosity and accelerate contrast excretion, thus reducing the
exposure time of tubular cells to its toxicity (4).
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Quality Control and the Learning
Curve of Transcatheter Aortic
Valve Implantation
With the introduction of transcatheter valves, the cardiologists and
cardiac surgeons have been faced with a new challenge, that is, to
keep efficacy and safety competitive in relation to conventional
surgery while implementing a new therapeutic strategy that re-
quires the acquisition of new skills and the close cooperation
between different specialties. In this complex scenario, the strict
monitoring of the overall and individual performance appears
mandatory. The paper by Alli et al. (1), recently published in
JACC: Cardiovascular Interventions, represents a commendable
attempt to characterize the learning curve of transcatheter aortic
valve implantation (TAVI) in terms of number of procedures
needed to become proficient with this technique, and to gain
insight into the steps that are critical for the successful initiation of
a TAVI program.
The paper by Alli et al. (1), however, is based on the retrospec-
tive analysis of outcome data arbitrarily divided into tertiles. This
rather traditional approach takes an average performance over
time; it may hide clusters of failure and may limit our understand-
ing of the learning process. A more appropriate statistical tool, in
our opinion, would be represented by time series analysis, and
specifically by the cumulative sum (CUSUM) analysis. These
methods report graphs of changes in outcome rates over time, and
allow for the real-time monitoring of the individual and team
performance, representing a particularly promising tool for mon-
itoring learning effect and performance (2).
During the last decade at our institution, there has been a
ramatic shift toward minimally invasive approaches for mitral
nd aortic valve surgery. The CUSUM analysis has been
outinely used to monitor the performance of the surgeons
ntroduced to this new technique with excellent results (3,4). It
was, therefore, natural to employ this methodology to assess the
performance of the TAVI team. It is interesting to observe that,
similar to what was reported by Alli et al. (1), the analysis of our
rst 70 patients showed that “proficiency” was obtained after
erforming about 30 cases. In particular, the lower boundary
ine (the line on the CUSUM chart indicating a complication
ate equal or inferior to the “accepted failure rate”), was crossed
t Patient #29.
The real strength of the CUSUM charts is that they allow one
o identify easily and quickly the ongoing trend. If the trendsuggests that the procedure is going out of control, the monitored
process can be analyzed in detail, and the right countermeasures
can be instituted. The failure of a TAVI procedure may be due to
several factors, many of which are not directly related to the
operative technique itself: by allowing the early identification of
negative trends, the CUSUM charts may prompt internal audits
aimed to the identification of the causes of failure, helping to take
the procedure back into control (2).
With the growing rate at which new techniques and technolo-
gies are introduced in cardiac surgery and interventional cardiol-
ogy, quality control will become a key issue in the near future. For
this reason Alli et al. (1) deserve merit for their pioneering paper.
However, we believe that time series analysis could be an excellent
means to analyze the performance of the TAVI teams, and we
would strongly suggest adopting this methodology to monitor the
learning curve for TAVI.
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We thank Dr. Cerillo and colleagues for their thoughtful and
insightful comments on our paper (1). In their letter, they have
highlighted the benefit of using time series analysis to assess
learning curve and quality control, and we generally agree with
their comments. The traditional method of assessing surgical
results is the retrospective analysis of outcome data as used in our
study. Statistical testing in this regard is an appropriate way of
assessing the learning curve when the interest is in determining
whether or not a difference has reached a magnitude of statistical
